Peter Normanis a pharmaceutical consultant and analyst based near Windsor, England. He has written and presented widely on various aspects of respiratory disease, generics, orphan drugs and on developments in therapeutic markets. Dr. Norman has over 30 years experience of the pharmaceutical industry in both R&D and competitive intelligence. His publications include many reviews and management reports in addition to original scientific papers and patents. Dr. Norman's interests also include novel drug developments, especially in the autoimmune and metabolic areas; and biosimilars.